IPHA - Rasio utang marang kapitalisasi buku Innate Pharma S.A.

The price action of Innate Pharma S.A. (IPHA) on the GURU.Markets platform, which currently stands at 0.00, reflects the dynamics of a business implementing AI and robotics for antibody creation. However, geopolitical fragmentation is hindering global testing and the supply of bio-resources. The company's growth relies on a strategic alliance with leading oncology centers, enabling the funding of scientific research without the need for merger and acquisition deals.

IPHA Innate Pharma S.A.: Rasio utang marang kapitalisasi buku ing interval 04.07.2022 - 27.10.2026

Ringkesan rincian data analitis Innate Pharma SA (IPHA)

- rega lan prakiraan konsensus rega:

Rega saham Innate Pharma S.A.|IPHA - Target konsensus

- data kapitalisasi pasar:

Nilai pasar Innate Pharma S.A|IPHA - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Innate Pharma|IPHA - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku innate-pharma.com|IPHA - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Innate Pharma S.A.|IPHA - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Innate Pharma, S.A.|IPHA - Utang kumulatif perusahaan|Utang marang nilai buku Innate Pharma S.A

Analisis kabeh metrik perusahaan:IPHA, Innate Pharma S.A.

This metric determines the proportion of borrowed funds relative to the total value of assets minus liabilities, measuring the business's degree of financial autonomy. By analyzing the level of debt concentration within the balance sheet capitalization, an investor assesses the risk of credit pressure, which is critically important for Innate Pharma S.A. (IPHA), whose stability is supported by strategic alliances with big pharma and the retention of a unique staff of NK-cell researchers.

Pesaing Innate Pharma S.A.